Accordingly, transcription of caspase-3 in four different NSCLC samples (SCC n = 3, AC n = 1) did not exhibit a significant upregulation in response to any of the cytotoxic drugs, which is in marked contrast to the highly responsive SCLC (Fig. 4). This evidence concerns the gene CASP3 and small cell lung carcinoma.